Trade Summary

2 months ago, Hamilton Thomas Edward, serving as Dir at Larimar Therapeutics, Inc. (LRMR), purchased 100,000 shares at $5.00 per share, for a total transaction value of $500,000.00. Following this transaction, Hamilton Thomas Edward now holds 824,231 shares of LRMR.

This purchase represents a 14.00% increase in Hamilton Thomas Edward's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, February 27, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 2, 2026, 3 days after the trade was made.

Larimar Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.